PLAY PODCASTS
The BioMedWire Podcast

The BioMedWire Podcast

[email protected]

128 episodesEN

Show overview

The BioMedWire Podcast has been publishing since 2020, and across the 6 years since has built a catalogue of 128 episodes. That works out to roughly 30 hours of audio in total. Releases follow a monthly cadence.

Episodes typically run under ten minutes — most land between 7 min and 19 min — with run-times ranging widely across the catalogue. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language News show.

The show is actively publishing — the most recent episode landed 5 days ago, with 20 episodes already out so far this year. The busiest year was 2020, with 48 episodes published. Published by [email protected].

Episodes
128
Running
2020–2026 · 6y
Median length
8 min
Cadence
Monthly

From the publisher

Fast-paced interviews with experts guiding the next wave of pharmaceutical and biotech innovation

Latest Episodes

View all 128 episodes

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

Jun 26, 202620 min

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis [Video Edition]

Jun 26, 202620 min

Next-Generation DNA Repair Therapies Open New Frontiers in Oncology

Jun 26, 202621 min

Next-Generation DNA Repair Therapies Open New Frontiers in Oncology [Video Edition]

Jun 26, 202621 min

How Advanced Drug Delivery Could Improve Existing Cancer Treatments

Jun 5, 202621 min

How Advanced Drug Delivery Could Improve Existing Cancer Treatments [Video Edition]

Jun 5, 202621 min

BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM)

Jun 2, 202617 min

BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) [Video Edition]

Jun 2, 202617 min

CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities

May 15, 202619 min

CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities [Video Edition]

May 15, 202619 min

The Next Generation of the GLP-1 Revolution Is Already Underway

May 15, 202622 min

The Next Generation of the GLP-1 Revolution Is Already Underway [Video Edition]

May 15, 202622 min

When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech

Apr 24, 202618 min

When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech [Video Edition]

Apr 24, 202618 min

BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc. (NASDAQ: SNGX)

Mar 19, 202628 min

BioMedWire Podcast Featuring the Return of Dr. Christopher Schaber, CEO of Soligenix Inc. (NASDAQ: SNGX) [Video Edition]

Mar 19, 202628 min

Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A

Feb 23, 202618 min

Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A [Video Edition]

Feb 23, 202618 min

The BioMedWire Podcast featuring Earth Science Tech Inc. (OTC: ETST) CEO Giorgio R. Saumat

Feb 17, 202614 min

The BioMedWire Podcast featuring Earth Science Tech Inc. (OTC: ETST) CEO Giorgio R. Saumat [Video Edition]

Feb 17, 202614 min